Alector, Inc.

The current price of ALEC is $2.09 — it has decreased by 8.33% since the previous close. Data as of Nov 5, 2026.

ALEC is down 5.00% over the past week, up 5.03% over the past month and up 67.20% over the past year. The price is above its 200-day moving average of $2.04.

Analysts' average 12-month price target for ALEC is $2.25, which implies 7.66% upside from the current price. Individual estimates range from $1.50 to $3.00.

Of the 7 analysts covering Alector, Inc., 3 rate it a buy, 2 rate it a hold, 1 rates it a sell and 1 rates it a strong sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

Alector, Inc. has a market capitalization of $233.36M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Alector, Inc. posted a loss of $0.21 per share against an estimate of -$0.2286, beating expectations by 8.12%. Upcoming reports are listed in the earnings calendar.

Alector, Inc. reported revenue of $3.32M in its most recent quarter, which has decreased by 57.84% compared with the same quarter a year earlier. Analysts had expected $1.71M.

Companies most comparable to Alector, Inc. include Vor Biopharma Inc., Opus Genetics, Inc., Fate Therapeutics, Inc., PepGen Inc. and Molecular Partners AG.

In the latest trading session ALEC moved between $2.03 and $2.28, a range of 11.96% of its current price.

Over the past 52 weeks ALEC has traded between $1.09 and $2.76. The current price is 24.28% below its 52-week high.